Holen Sie sich die Stockscreener-App
3.905
1.30%
0.055
Schlusskurs vom Vortag:
$3.85
Offen:
$3.89
24-Stunden-Volumen:
124.17K
Relative Volume:
0.09
Marktkapitalisierung:
$566.31M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-4.3365
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
+14.71%
1M Leistung:
+5.69%
6M Leistung:
+41.30%
1J Leistung:
-36.38%
1-Tages-Spanne:
$3.85
$3.94
1-Wochen-Bereich:
$3.38
$4.015
52-Wochen-Spanne:
$1.665
$6.05
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Firmenname
Maravai Lifesciences Holdings Inc
Sektor
Branche
Telefon
(858) 546-0004
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Vergleichen Sie MRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.905 | 558.34M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.67 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.37 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
813.75 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.69 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Neutral |
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Stifel | Buy |
| 2020-12-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-14 | Eingeleitet | UBS | Buy |
Alle ansehen
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Can Maravai LifeSciences Holdings Inc. stock withstand economic slowdown2025 Valuation Update & Weekly Market Pulse Updates - ulpravda.ru
Why Maravai LifeSciences Holdings Inc. stock is in analyst buy zoneJuly 2025 Sentiment & Weekly High Conviction Ideas - ulpravda.ru
How MACOM Technology Solutions Holdings Inc. stock trades during market volatilityJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - ulpravda.ru
Is Maravai LifeSciences Holdings Inc. stock oversold or undervaluedTrade Entry Report & Verified Momentum Stock Ideas - ulpravda.ru
Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMACD Trading Signals & Rapid Portfolio Investment - ulpravda.ru
How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingStock Watchlist Updates & Free Trading Psychology Coaching - ulpravda.ru
How buybacks impact Maravai LifeSciences Holdings Inc. stock valueEarnings Revision Updates & Identify Winning Stocks - ulpravda.ru
Volume Summary: Can Maravai LifeSciences Holdings Inc stock withstand economic slowdownJuly 2025 Analyst Calls & Consistent Profit Alerts - moha.gov.vn
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs - Kalkine Media
Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR - TradingView — Track All Markets
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat
Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - moha.gov.vn
Maravai LifeSciences Holdings Inc Stock Analysis and ForecastRSI Overbought/Oversold & Free Superior Trading Gains - earlytimes.in
Critical Analysis: Maravai LifeSciences (NASDAQ:MRVI) versus TerrAscend (OTCMKTS:TSNDF) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Investors Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.7%What's Next? - MarketBeat
Can Maravai LifeSciences Holdings Inc. (MAR) stock survive global slowdownEarnings Performance Report & Capital Efficient Trade Techniques - Улправда
Does Maravai LifeSciences Holdings Inc. stock trade at a discount to peersTrade Entry Report & AI Optimized Trade Strategies - Улправда
Shorts Report: How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | NDAQ:MRVI | Press Release - Stockhouse
Can Maravai LifeSciences Holdings Inc. stock attract ESG capital inflowsOil Prices & Free Verified High Yield Trade Plans - Улправда
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Why Analysts See Maravai’s Story Shifting After Target Cut And Washed Out Share Price Range - Yahoo Finance
Wells Fargo maintains Maravai LifeSciences Holdings (MRVI) overweight recommendation - MSN
MRVI: Wells Fargo Maintains Rating and Raises Price Target | MRV - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences LawsuitMRVI - ACCESS Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRVI - 28/22 News
Maravai LifeSciences Holdings, Inc. $MRVI Stock Holdings Boosted by Immersion Corp - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Director Purchases $190,446.40 in Stock - MarketBeat
Maravai Lifesciences (MRVI) Director Acquires 100K Shares - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences delivers 60% return after March fair value alert By Investing.com - Investing.com Canada
Maravai LifeSciences delivers 60% return after March fair value alert - Investing.com
Harspring Capital Management LLC Acquires New Shares in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Geode Capital Management LLC Has $7.19 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. (MAR) stock justify high valuationPortfolio Profit Report & Precise Swing Trade Alerts - Newser
Will Maravai LifeSciences Holdings Inc. (MAR) stock sustain dividend payouts2025 Investor Takeaways & Weekly Consistent Profit Watchlists - Newser
Maravai LifeSciences Reports Q3 2025 Financial Results - MSN
A new trading data show Maravai LifeSciences Holdings Inc (MRVI) is showing positive returns. - Setenews
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):